.Merck trumps earnings expectations, increases purchases overview on solid need for leading drugs like Keytruda CNBCMerck & Co. (MRK United States) Trumps Revenue Forecasts as Keytruda Purchases Growth BloombergMerck Inventory: Pharma Titan Posts Powerful End Results, But Expectation Tumbles Short Client's Service DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck beats earnings and purchases requirements in the middle of Keytruda advantage, yet provides combined full-year outlook MarketWatch.